Today's pre-market stock movers: X, REV, ROKU, BHC and more
Gainers:
• $Aurora Mobile (JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Roku Inc (ROKU.US)$ +4.2% (ROKU and $Walmart (WMT.US)$ announce partnership to bring comerce to TV ads)
• $Sierra Oncology (SRRA.US)$ +3.8% (announces submission of new drug application for Momelotinib to FDA)
• $Bitfarms (BITF.US)$ +3.8% (entered into an equipment financing agreement with initial funding of $37 million)
• $Bausch Health (BHC.US)$ +3% (provides update on Solta Medical; IPO process suspended in light of market conditions)
• $Centene (CNC.US)$ +2.3% (raises FY22 outlook ahead of Investor Day; authorizes $3.0 bln increase to existing stock repurchase program)
• $Titan International (TWI.US)$ +1.6% (entered into a global long-term agreement with $Deere (DE.US)$ on June 13 to supply wheels and tires)
• $Dana (DAN.US)$ +1.5% (awarded a $2.7 million (2 million) grant to develop an e-Powertrain for OX Delivers)
• $Aerojet Rocketdyne (AJRD.US)$ +1.4% (CEO Eileen Drake and Committee for Aerojet Rocketdyne Shareholders and Value Maximization Extremely Pleased with Delaware Court's Opinion)
• $Oasis Petroleum (OAS.US)$ +1.2% (declares $15 special dividend in connection with closing of merger with $Whiting Petroleum (WLL.US)$)
• $JATT Acquisition Corp (JATT.US)$ +1% (JATT Acquisition Corp and Zura Bio Limited announce definitive business combination agreement to create NYSE listed biotechnology company)
Analyst comments:
Losers:
• $Rhythm Pharmaceuticals (RYTM.US)$ -5.1% (FDA issues CRL for the sNDA for setmelanotide in Alstrm syndrome; FDA approves sNDA for IMCIVREE; also enters into Revenue Interest Financing Agreement with Healthcare Royalty for a total investment up to $100 mln)
• $Global Cord Blood (CO.US)$ -2.3% (FDA recently cleared Cellenkos' IND application for CK0804 as add on therapy to Ruxolitinib)
• $Targa Resources (TRGP.US)$ -0.8% (to acquire Lucid Energy for $3.55 bln; also updates 2022 stand alone outlook)
Analyst comments:
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment